Starsource Multitrade Limited, formerly Chemo Pharma Laboratories Limited, is an India-based company. The Company was engaged in manufacturing operations. It has no operations and does not generate any revenue. The Company is exploring new business opportunities.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
18/09/26	₹73.44	0.00%	25
17/09/26	₹73.44	+3.42%	109
16/09/26	₹71.01	-2.39%	161
11/09/26	₹72.75	-1.01%	1
10/09/26	₹73.49	-2.74%	144

Delayed Quote Bombay S.E.

More quotes

Delayed Bombay S.E. 09:17:05 18/09/2026 +03			5-day change	1st Jan Change
73.44 ^INR	0.00%		+0.95%	-35.97%

08-14	Starsource Multitrade Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	110M 1.15M 1M 948K 861K 1.61M 1.62M 11.29M 4.37M 55.98M 4.32M 4.22M 179M	P/E 2025	54.6x	P/E 2026	-1.41x
Enterprise Value	97M 1.01M 882K 835K 759K 1.42M 1.42M 9.94M 3.85M 49.29M 3.8M 3.72M 158M	EV / Sales 2025	13x	EV / Sales 2026	28x
Free-Float	61.17%	Yield 2025 *	-	Yield 2026	-

08-14	Starsource Multitrade Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-12	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	Starsource Multitrade Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
01/10/25	Chemo Pharma Laboratories Limited has Changed its Name to Starsource Multitrade Limited	CI
25/09/25	Chemo Pharma Laboratories Limited Announces Changes to Its Board	CI
25/09/25	Chemo Pharma Laboratories Limited Appoints and Regularize Utsav Trivedi as CFO	CI
25/09/25	Chemo Pharma Laboratories Limited Appoints and Regularize Ruchit Mehta as Chief Executive Officer	CI
12/09/25	Chemo Pharma Laboratories Limited Announces Company Secretary and Compliance Officer, Effective from September 12, 2025	CI
12/08/25	Chemo Pharma Laboratories Limited Decides to Shift the Registered Office	CI
12/08/25	Chemo Pharma Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
29/05/25	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
27/05/25	Chemo Pharma Laboratories to Open New Corporate Office in Ahmedabad, India; Shares Down 4%	MT

1 week	+0.95%
Current month	-13.40%
1 month	-18.81%
3 months	-29.72%
6 months	-15.40%
Current year	-35.97%

Starsource Multitrade Limited Stock

Stocks

CHEMOPH6

INE320M01019

Investment Holding Companies

Valuation: Starsource Multitrade Limited

Chart: Starsource Multitrade Limited

Latest news: Starsource Multitrade Limited

Quotes and Performance

Price Extremes

Managers and Directors: Starsource Multitrade Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	70.01	74.5
1 month	70.01	94.15
Current year	70.01	152.9
1 year	70.01	152.9
3 years	28	154
5 years	22.7	154
10 years	5.45	154

Manager	Title	Age	Since
Ruchit Mehta CEO	Chief Executive Officer	35	16/04/2025
Utsav Trivedi DFI	Director of Finance/CFO	27	16/04/2025
Aditya Agarwal CMP	Compliance Officer	-	12/09/2025

Director	Title	Age	Since
Simran Ankleshwar Tripathi BRD	Director/Board Member	-	31/12/2024
Ruchit Mehta BRD	Director/Board Member	35	16/04/2025
Simran Utsav Trivedi BRD	Director/Board Member	30	31/12/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STARSOURCE MULTITRADE LIMITED	0.00%	+0.95%	-38.18%	+136.90%	1.15M
CHURCHILL CAPITAL CORP XI	-0.12%	-5.74%	-	-	673M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.15%	+0.05%	-	-	648M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.59%	0.00%	-	-	602M
CHURCHILL CAPITAL CORP XII	+0.23%	+0.18%	-	-	597M
CANTOR EQUITY PARTNERS IV, INC.	-0.05%	+0.14%	+2.02%	-	593M
CENTIEL AG	+5.10%	+8.04%	+274.55%	-75.28%	612M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.18%	-2.02%	-	-	551M
CHURCHILL CAPITAL CORP XIII	+0.35%	+0.68%	-	-	512M
Average	+0.67%	+0.14%	+79.46%	+30.81%	532.06M
Weighted average by Cap.	+0.77%	+0.11%	+140.27%	-74.88%

	2025	2026
Net sales	6.2M 64.72K 56.37K 53.35K 48.47K 90.56K 91K 635K 246K 3.15M 243K 238K 10.08M	5.5M 57.38K 49.98K 47.3K 42.98K 80.29K 80.68K 563K 218K 2.79M 216K 211K 8.94M
Net income	3.42M 35.73K 31.12K 29.45K 26.76K 50K 50.24K 351K 136K 1.74M 134K 131K 5.57M	-119M -1.24M -1.08M -1.02M -927K -1.73M -1.74M -12.15M -4.7M -60.25M -4.65M -4.55M -193M
Net Debt	-106M -1.11M -966K -914K -831K -1.55M -1.56M -10.89M -4.21M -53.99M -4.17M -4.07M -173M	-13.16M -137K -120K -113K -103K -192K -193K -1.35M -522K -6.69M -516K -505K -21.41M